These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 8138393)

  • 1. Protection of mice against mycobacterial infection by lymphoid cell vaccination.
    Levy L; Enk CD; Zipris D; Cohen IR
    Isr J Med Sci; 1994 Jan; 30(1):22-5. PubMed ID: 8138393
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reconstitution of Mycobacterium leprae immunity in severe combined immunodeficient mice using a T-cell line.
    Azouaou N; Gelber RH; Abel K; Sasaki DT; Murray LP; Locksley RM; Mohagheghpour N
    Int J Lepr Other Mycobact Dis; 1993 Sep; 61(3):398-405. PubMed ID: 8228438
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunity to leprosy. III. The in vitro induction of B lymphocyte proliferation by mycobacteria.
    Douglas-Jones AG; Wade S; Kent D; Vaughan R; Watson JD
    Int J Lepr Other Mycobact Dis; 1986 Mar; 54(1):63-70. PubMed ID: 3086467
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Study on the roles of CD4+ and CD8+ T cells in the expression of host resistance to Mycobacterium leprae infection induced in athymic nude mice.
    Maw WW; Tomioka H; Sato K; Yamada Y; Saito H
    Int J Lepr Other Mycobact Dis; 1995 Dec; 63(4):539-45. PubMed ID: 8642217
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of hsp65 DNA vaccination carrying immunostimulatory DNA sequences (CpG motifs) against Mycobacterium leprae multiplication in mice.
    Nomaguchi H; Mukai T; Takeshita F; Matsuoka M; Maeda Y; Aye TM; Jahan N; Yogi Y; Endo M; Sato Y
    Int J Lepr Other Mycobact Dis; 2002 Sep; 70(3):182-90. PubMed ID: 12483966
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Limiting dilution of murine T cell response to mycobacterial antigens.
    Launois P; Maillere B; Dieye A; Sarthou JL; Bach MA
    Acta Leprol; 1989; 7 Suppl 1():179-80. PubMed ID: 2503983
    [No Abstract]   [Full Text] [Related]  

  • 7. Vaccination of mice against the leprosy bacillus with skin-test antigens.
    Ngamying M; Levy L; Brennan PJ
    Int J Lepr Other Mycobact Dis; 1999 Sep; 67(3):305-7. PubMed ID: 10575412
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of vaccination with several mycobacterial proteins and lipoproteins on Mycobacterium leprae infection of the mouse.
    Ngamying M; Varachit P; Phaknilrat P; Levy L; Brennan PJ; Cho SN
    Int J Lepr Other Mycobact Dis; 2001 Mar; 69(1):43-5. PubMed ID: 11480318
    [No Abstract]   [Full Text] [Related]  

  • 9. The study of Mycobacterium leprae infection in interferon-gamma gene--disrupted mice as a model to explore the immunopathologic spectrum of leprosy.
    Adams LB; Scollard DM; Ray NA; Cooper AM; Frank AA; Orme IM; Krahenbuhl JL
    J Infect Dis; 2002 Feb; 185 Suppl 1():S1-8. PubMed ID: 11865434
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Frontier of mycobacterium research--host vs. mycobacterium].
    Okada M; Shirakawa T
    Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antigen-specific Il-4- and IL-10-secreting CD4+ lymphocytes increase in vivo susceptibility to Trypanosoma cruzi infection.
    Barbosa de Oliveira LC; Curotto de Lafaille MA; Collet de Araujo Lima GM; de Almeida Abrahamsohn I
    Cell Immunol; 1996 May; 170(1):41-53. PubMed ID: 8660798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The immunological and epidemiological significance of environmental mycobacteria on leprosy and tuberculosis control.
    Pallen MJ
    Int J Lepr Other Mycobact Dis; 1984 Jun; 52(2):231-45. PubMed ID: 6427125
    [No Abstract]   [Full Text] [Related]  

  • 13. Experimental Mycobacterium leprae infection in BALB/c mice: effect of BCG administration on TNF-alpha production and granuloma development.
    Aarestrup FM; Sampaio EP; de Moraes MO; Albuquerque EC; Castro AP; Sarno EN
    Int J Lepr Other Mycobact Dis; 2000 Jun; 68(2):156-66. PubMed ID: 11036496
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Susceptibility to Mycobacterium leprae of ALY (alymphoplasia) mice and IFN-gamma induction in the culture supernatant of spleen cells.
    Yogi Y; Endoh M; Banba T; Okamura H; Nomaguchi H
    Int J Lepr Other Mycobact Dis; 1998 Dec; 66(4):464-74. PubMed ID: 10347567
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of atypical mycobacterial infection on the cell-mediated immunity induced by Mycobacterium bovis BCG in mice. II. Suppression of protective immunity].
    Nakamura RM
    Kekkaku; 1993 May; 68(5):361-5. PubMed ID: 8331880
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effective vaccination of mice against Mycobacterium leprae with density-gradient subfractions of soluble M. leprae proteins: clues to effective protein epitopes.
    Gelber RH; Hunter SW; Murray LP; Siu P; Tsang M; Brennan PJ
    Lepr Rev; 1994 Sep; 65(3):175-80. PubMed ID: 8942148
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vaccination with DNA of the Mycobacterium tuberculosis 85B antigen protects mouse foot pad against infection with M. leprae.
    Roche PW; Neupane KD; Failbus SS; Kamath A; Britton WJ
    Int J Lepr Other Mycobact Dis; 2001 Jun; 69(2):93-8. PubMed ID: 11757171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Susceptibility of severe combined immunodeficient mice to Mycobacterium leprae.
    Ishaque M; Sticht-Groh V; Togola D
    Microbios; 1996; 88(354):19-26. PubMed ID: 9121376
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Accelerating the secondary immune response by inactivating CD4(+)CD25(+) T regulatory cells prior to BCG vaccination does not enhance protection against tuberculosis.
    Quinn KM; Rich FJ; Goldsack LM; de Lisle GW; Buddle BM; Delahunt B; Kirman JR
    Eur J Immunol; 2008 Mar; 38(3):695-705. PubMed ID: 18266274
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Naive, effector, and memory CD8 T cells in protection against pulmonary influenza virus infection: homing properties rather than initial frequencies are crucial.
    Cerwenka A; Morgan TM; Dutton RW
    J Immunol; 1999 Nov; 163(10):5535-43. PubMed ID: 10553081
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.